IONIQ Sciences Joins Newly Formed BioHive
In News
We are proud to be a key supporter and member of the newly formed BioHive,...
Read More
IONIQ Sciences announces its ProLung Test has been formally accepted for submission to China’s National Medical Products Administration
In News
Salt Lake City, UT, September 17, 2020 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ Sciences announces Dr. Ørjan G. Martinsen has joined its Scientific Advisory Committee
In News
Salt Lake City, UT, August 17, 2020 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ Sciences announces Dr. Benjamin Sanchez has joined its Scientific Advisory Committee
In News
Salt Lake City, UT, August 14, 2020 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”),...
Read More
IONIQ Sciences announces institutional offering
In News
IONIQ Sciences announces institutional offering Salt Lake City, UT, May 28, 2020 – IONIQ Sciences Inc....
Read More
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
In News
Salt Lake City, UT, May 27, 2020 – IONIQ Sciences Inc. (“IONIQ Sciences” or the...
Read MoreProLung Announces Fully Subscribed Private Placement of $3.3 Million
In News
Salt Lake City, UT, May 22, 2020 – ProLung, Inc. (“ProLung” or the “Company”), which has...
Read More
ProLung Test is honored as “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global Health & Pharma
ProLung has been awarded the “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global...
Read More
In Their Words: Jared Bauer
In Their Words: Jared Bauer Utah has an incredibly strong life sciences community with a rich...
Read More
ProLung Test Granted ‘Breakthrough Device’ Designation by the FDA
ProLung Test Granted ‘Breakthrough Device’ Designation by the FDA Salt Lake City, UT, February 13, 2020...
Read More